Andreas Wunder
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Optical Imaging and Spectroscopy Techniques 6
- Co-authors
- G. Stehle (10 shared papers)Hannsjörg Sinn (10 shared papers)D. L. Heene (9 shared papers)Jan Klohs (11 shared papers)W. Maier‐Borst (7 shared papers)G. Hartung (7 shared papers)Ulf Müller‐Ladner (3 shared papers)Ulrich Dirnagl (13 shared papers)
- Journals
- Anti-Cancer Drugs (5 papers)Journal of Cerebral Blood Flow & Metabolism (5 papers)Journal of Clinical Investigation (3 papers)International Journal of Cancer (3 papers)Basic Research in Cardiology (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Wunder
55 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 111
- Neurology 220
- Biomaterials 259
- Cancer Research 270
- Radiology, Nuclear Medicine and Imaging 372
- Molecular Biology 802
Countries citing papers authored by Andreas Wunder
This map shows the geographic impact of Andreas Wunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Wunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Wunder more than expected).
Fields of papers citing papers by Andreas Wunder
This network shows the impact of papers produced by Andreas Wunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Wunder. The network helps show where Andreas Wunder may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Wunder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 250 | |
| 2 | 2002 | 185 | |
| 3 | 2003 | 179 | |
| 4 | 2002 | 147 | |
| 5 | 2004 | 125 | |
| 6 | 2011 | 109 | |
| 7 | 1997 | 91 | |
| 8 | 2008 | 81 | |
| 9 | 1997 | 59 | |
| 10 | 2009 | 58 | |
| 11 | 2009 | 54 | |
| 12 | 2003 | 48 | |
| 13 | 2012 | 43 | |
| 14 | 1999 | 43 | |
| 15 | 2005 | 36 | |
| 16 | 2008 | 35 | |
| 17 | 2013 | 35 | |
| 18 | 2011 | 34 | |
| 19 | 1998 | 29 | |
| 20 | 2012 | 19 |
About Andreas Wunder
Andreas Wunder is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Cognitive Neuroscience, Pharmacology and Oncology, having authored 55 papers that have together received 2.0k indexed citations. Recurring topics across this work include Functional Brain Connectivity Studies (10 papers), Treatment of Major Depression (9 papers), Optical Imaging and Spectroscopy Techniques (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Photoacoustic and Ultrasonic Imaging (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Inflammatory Bowel Disease (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Neurology (220 citations), Biomaterials (259 citations), Cancer Research (270 citations), Radiology, Nuclear Medicine and Imaging (372 citations) and Molecular Biology (802 citations). Andreas Wunder has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include G. Stehle, Hannsjörg Sinn, D. L. Heene, Jan Klohs, W. Maier‐Borst, G. Hartung, Ulf Müller‐Ladner, Ulrich Dirnagl, Georg Breier and Ralf Erber. Their work appears in journals such as Anti-Cancer Drugs, Journal of Cerebral Blood Flow & Metabolism, Journal of Clinical Investigation, International Journal of Cancer and Basic Research in Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.